医学
内科学
心肌梗塞
心脏病学
临床终点
狼牙棒
血运重建
不利影响
心力衰竭
入射(几何)
临床试验
终点测定
观察研究
光学相干层析成像
前瞻性队列研究
部分流量储备
限制
支架
无症状的
外科
病变
队列研究
随机对照试验
心血管事件
放射科
易损斑块
心肌梗死诊断
代理终结点
磁共振成像
临床意义
梗塞
试验预测值
作者
Rick H J A Volleberg,Jan‐Quinten Mol,Geert A A Versteeg,Joske van der Zande,Anouar Belkacemi,Renicus S Hermanides,M Meuwissen,Alexey V Protopopov,Peep Laanmets,Oleg Krestyaninov,Casper F Laclé,Rohit M. Oemrawsingh,Jan‐Peter van Kuijk,Karin Arkenbout,Dirk J. van der Heijden,Saman Rasoul,Erik Lipsic,Laura Rodwell,Cyril Camaro,Peter Damman
出处
期刊:Eurointervention
[European Association of Percutaneous Cardiovascular Interventions]
日期:2026-08-01
卷期号:22 (16): 864-873
标识
DOI:10.4244/eij-d-26-00416
摘要
BACKGROUND: High-risk plaques (HRP) in non-flow-limiting, deferred non-culprit lesions have been associated with adverse short-term cardiovascular outcomes after myocardial infarction (MI). However, the long-term prognostic implications remain largely unknown. AIMS: This study sought to evaluate the long-term association between HRP and clinical outcome after MI Methods: In the prospective, observational PECTUS-obs study, 438 patients with recent MI underwent optical coherence tomography (OCT) of all fractional flow reserve-negative non-culprit lesions. Patients were grouped according to the presence or absence of at least one OCT-identified HRP. The current study evaluates the final long-term outcome. The primary patient-level endpoint was defined as major adverse cardiovascular events (MACE), a composite of cardiac death, non-fatal MI, or unplanned revascularisation, excluding all periprocedural, indeterminate, and stent failure-related events. RESULTS: After a median follow-up of 1,828 days (interquartile range [IQR] 1,821-1,842), the presence of at least one HRP was associated with MACE (hazard ratio [HR] 1.87, 95% confidence interval [CI]: 1.11-3.14; p=0.017). Among the individual endpoint components, non-fatal MI (HR 4.07, 95% CI: 1.23-13.52; p=0.013) and unplanned revascularisation (HR 1.97, 95% CI: 1.07-3.64; p=0.027) occurred more frequently in patients with at least one HRP. In an exploratory landmark analysis, the risk associated with presence of HRP was observed only during the first 2 years of follow-up. The lesion-level incidence of target lesion failure did not differ significantly between groups (HR 1.65, 95% CI: 0.91-2.96; p=0.097). CONCLUSIONS: Non-flow-limiting, high-risk non-culprit plaques are associated with adverse patient-level clinical outcomes during long-term follow-up after MI, potentially with a more pronounced short-term risk. CLINICALTRIALS: gov: NCT03857971.